Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1996 Apr;87(4):385-94.
doi: 10.1111/j.1349-7006.1996.tb00234.x.

Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness

Affiliations
Comparative Study

Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness

T Hasebe et al. Jpn J Cancer Res. 1996 Apr.

Abstract

Histological examination of invasive ductal carcinoma of the breast often demonstrates the presence of an extensive central fibrotic focus (FF). The clinicopathological significance of the FF, or scar, in primary invasive ductal carcinoma is still ambiguous. One hundred and fifty-three cases of invasive ductal carcinoma (IDC) were classified into two groups, those with and those without FF. The differences in frequency of immunohistochemically detected overexpression of c-erbB-2 protein and nuclear accumulation of p53 protein, and the labeling index of proliferating cell nuclear antigen (PCNA), as well as histopathological parameters were compared between these two groups. IDCs smaller than 50 mm with FF showed a higher frequency of high-grade tumors, a higher frequency of lymph node metastasis, and a significantly higher frequency of c-erbB-2 protein overexpression than those without FF. In tumors of 20 mm or less, the incidence of nuclear accumulation of p53 protein was significantly higher in tumors with than those without FF. Tumors with FF showed a significantly higher PCNA labeling index than those without FF, regardless of tumor size. The present results indicate that the presence of FF is an important clinicopathological parameter associated with a higher degree of malignancy in IDCs, especially those smaller than 50 mm. Therefore, dividing IDCs into those with and those without FF appears to be meaningful clinicopathologically.

PubMed Disclaimer

References

    1. ) Linell , F. , Ljungberg , O. and Andersson , I.Breast carcinoma. Aspects of early stages, progression, and related problems . Acta Pathol. Microbiol. Scand. , 272 ( Suppl. ), 1 – 101 ( 1980. ). - PubMed
    1. ) Fisher , E. R. , Palekar , A. S. , Sass , R. and Fisher , B.Scar cancers: pathologic findings from the national surgical adjuvant breast project (protocol No. 4), IX . Breast Cancer Res. Treat. , 3 , 39 – 59 ( 1983. ). - PubMed
    1. ) Toikkanen , S. and Joensuu , H.Long‐term prognosis of scar and non‐scar cancers of the breast . APMIS , 98 , 1033 – 1038 ( 1990. ). - PubMed
    1. ) Partanen , S. and Hyvarinen , H.Scar and non‐scar ductal cancer of the female breast. Observations on patient age, tumour size, and hormone receptors . Virchow Arch. A Pathol. Anat. , 412 , 145 – 149 ( 1987. ). - PubMed
    1. ) Slanion , D. J. , Clark , G. M. , Wong , S. Q. , Levin , W. J. , Ullrigh , A. and McGuire , W. L.Human breast cancer: correlation of relapse and survival with amplification of the HER.‐2+neu oncogene . Science , 235 , 177 – 182 ( 1987. ). - PubMed

Publication types

Substances